Groowe Groowe / Newsroom / ABBV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABBV News

ABBVIE INC.

SLE Market Evolution Accelerates as AstraZeneca’s Saphnelo SC Emerges as a Likely Key Challenger to GSK’s Benlysta

globenewswire.com
GSK AZN BIIB BMY ABBV

Neomorph Announces Closing of $100 Million Series B Financing

globenewswire.com
NVO BIIB ABBV

Antibody Drug Conjugates (ADC) Market Research and Competitive Landscape Report 2026 - Extensive Analysis of Over 180 Companies and More Than 290 Drugs

globenewswire.com
GILD ABBV IPHA

Follicular Lymphoma Market Insight, Epidemiology, and Forecasts, 2022-2026 & 2026-2036

globenewswire.com
AZN GILD ABBV REGN BIIB

Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

prnewswire.com
ABBV

AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026

prnewswire.com
ABBV

7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments

globenewswire.com
ABBV GSK AZN GILD REGN

BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year

prnewswire.com
ABBV

SAS Innovate 2026 to feature new health care and life sciences AI capabilities and real-world use cases

prnewswire.com
JNJ AZN GILD REGN SNY IQV OGN PFE ABBV ELV CI

Cancer and Careers Announces Inaugural Index of Best Companies for Working with Cancer

prnewswire.com
BBY GOOGL MAR ABBV MRK PFE SNY STLA